Clinical trial · Interventional
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
NCT00973856CI-TRIAL-00063561completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective is to conduct a pilot study to determine the effectiveness of PURELL VF481 to treat warts located on the hands.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Condylomata Acuminata | — | UNRESOLVED | — |
| Epidermodysplasia Verruciformis | — | UNRESOLVED | — |
| Papillomavirus Infections | — | UNRESOLVED | — |
| Warts | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Placebo Solution | Other | — | UNRESOLVED |
| PURELL VF481 | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- PURELL Left Hand/ Placebo Right Hand
- description
- One product will be assigned to each hand to minimize treatment confusion for the participants. PURELL VF481 Left Hand/ Placebo Right Hand
- interventionNames
- Other: PURELL VF481
- Other: Placebo Solution
- type
- PLACEBO_COMPARATOR
- label
- Placebo Solution Left Hand/ PURELL Right hand
- description
- One (1) product will be assigned to each hand to minimize treatment confusion for the participants PURELL VF481 Right Hand/ Placebo Left Hand One (1) pump of test product (approximately 1.5ml) is applied to a wooden applicator and gently rubbed into the wart, then covered with a latex free adhesive bandage (it is not necessary to wait until dry) each night before bed
- interventionNames
- Other: PURELL VF481
- Other: Placebo Solution
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with 2+ warts being seen at a Dermatologist's office * 2 or more warts on the hands that are located at least 1 cm apart or on separate fingers * Warts must have been present for at least 2 months * Wart size must be between 2 mm-15 mm in diameter * Participants must be in good general health * Participants must be able to speak and read in English. * Participant must be able to read and sign participant instruction sheet, and informed consent and authorization. * Subjects must be able to understand and execute the instructions presented in pictorial form. Exclusion Criteria: * Pregnancy (Patients will be asked to verify using criteria of contraception, menstrual cycle, and pregnancy test, if necessary). * Treatment of warts with other methods such as salicylic acid, etc., in the past 14 days. * Known allergies to common topical antimicrobials or the individual ingredients in either test product. * Participation in a clinical study in the past 7 days or participation in another clinical study * Unwillingness to perform requirements of the study * Any medical condition that should preclude participation in the study, at the discretion of the physician * Missed ≥ 6 of the treatments in a 4 week study period
References
Publications (0)
Data not yet available
No reference posted for this study.